genedrive (LON:GDR) Trading Down 0.2% – What’s Next?

Shares of genedrive plc (LON:GDR) dropped 0.2% during trading on Thursday . The stock traded as low as GBX 1.15 and last traded at GBX 1.22. Approximately 2,064,769 shares changed hands during mid-day trading, a decline of 69% from the average daily volume of 6,604,662 shares. The stock had previously closed at GBX 1.23.

genedrive Stock Down 0.2%

The company has a current ratio of 0.99, a quick ratio of 5.52 and a debt-to-equity ratio of -120.48. The firm has a market cap of £19.64 million, a P/E ratio of -1.55 and a beta of -0.04. The stock’s fifty day moving average is GBX 1.06 and its two-hundred day moving average is GBX 1.02.

genedrive (LON:GDR) last released its quarterly earnings results on Monday, March 30th. The company reported GBX (0.30) EPS for the quarter. genedrive had a negative return on equity of 1,044.57% and a negative net margin of 500.75%. As a group, research analysts anticipate that genedrive plc will post 209.9999867 earnings per share for the current year.

genedrive Company Profile

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.